Country | No. positive/ No. of sample tested | Prevalence | Genotypes (no.) | References |
---|---|---|---|---|
America | 13/413 | 3.15% | Genbank accession no AY257180 (13) | [25] |
America | 59/452 | 13.05% | Genbank accession no AY257180 (59) | [26] |
America | 32/338 | 9.47% | BEB1 (9), BEB4 (8), BEB2 (7), BEB5 (6), BEB3 (2) | [27] |
America | 131/571 | 22.94% | BEB2 (66), BEB1 (27), BEB4 (27), BEB3/BEB4 (4), BEB1/BEB2 (2), BEB1/BEB4 (1), BEB2/BEB4 (2), Peru 6 (1), Peru 9 or D (1) | [28] |
America | 24/541 | 4.44% | BEB1 (8), BEB2 (8), BEB4 (5), BEB6 (2), BEB7 (1) | [29] |
Korea | 80/538 | 14.87% | CEbE (3), CEbD (2), CEbB (2), CEbA (1), CEbF (1), CEbC (1) | [30] |
South America | 9/121 | 7.44% | BEB3-like (4), BEB4 (3), I (1), D (1) | [31] |
America | 285/819 | 34.80% | J (108), BEB4 (65), I (59), BEB8 (41), BEB9 (6), mixed I/BEB4 (3), J/BEB4 (2), Type IV (1) | [32] |
Czech Republic | 37/240 | 15.42% | I (6) | [22] |
Argentina | 10/70 | 14.29% | J (4), I (2), BEB4 (1), EbpC (1), BEB10 (1), D (1) | [33] |
China | 32/537 | 5.96% | J (7), CS-4 (3), I/Ja (3), BEB4 (1), EbpC (1), G (1), BEB4/Ja (1), CS-4/EbpCa (1), CS-4/NECA1a (1), CS-4/NECA3a (1), EbpC/NECA2a (1), NECA4/NECA5a (1) | [34] |
China | 40/133 | 30.08% | O (26), EbpA (2), I (2), J (2), CC-I (2), CC-II (2), CC-III (2), D (1), BEB4 (1) | [35] |
Egypt | 13/214 | 6.07% | - | [36] |
Brazil | 79/452 | 17.48% | I (33), BEB8 (19), BEB4 (5), BEB12 (5), D (4), BEB11 (3), BEB13 (2), EbpA (1), BEB8/BEB13 (1), BEB4/BEB16 (1), I/BEB13 (1), BEB8/BEB13/BEB15 (1), BEB4/I (1), BEB8/BEB13/BEB17 (1), BEB8/BEB13/BEB14 (1) | [37] |
China | 214/879 | 24.34% | J (77), I (61), CM8 (18), BEB6 (17), BEB4 (15), EbpC (6), COS-1 (5), EbpA (2), D (2), BEB8 (1), CD6 (1), CHC1 (1), CHC2 (1), CHC3 (1), CHC4 (1), CHC5 (1), CHG2 (1), CHG3 (1), H (1), O (1) | [38] |
China | 73/371 | 19.68% | I (40), J (30), CHN1 (1), CSX1 (1), CSX2 (1) | [39] |
Algeria | 11/108 | 10.8% | BEB4 (4), BEB6 (2), BEB3 (1), I (1), J(1), PtEb XI (1), mixed (1) | [40] |
China | 202/1040 | 19.42% | I (87), J (83), BEB4 (18), CHC8 (7), BEB6 (3), N (1), Ebpc (1), CHC6 (1), CHC7 (1), | [41] |
China | 85/514 | 16.54% | J (57), I (19), BEB4 (4), EbpC (2), D (2), CC4 (1) | [24] |
Iran | 36/256 | 14.06% | D (22), J (9), M (5) | [42] |
China | 214/809 | 26.45% | J (145), BEB4 (59), CHN4 (4), Type IV and BEB4 (4), CHN15 (1), mixed (1) | [43] |
China | 61/388 | 15.72% | J (57), D (3), J/D (1) | [9] |
China | 118/1440 | 8.19% | - | [44] |
Thailand | 3/60 | 5.00% | D (3) | [45] |
China | 177/1366 | 12.96% | J (138), I (21), BEB4 (10), Type IV (1), CHC17 (1) | [13] |
China | 33/277 | 11.91% | BEB6(10), COS-1(6), I(6), CHG2(1), CHG3(1), J(1), CHC9(1), CHC10(1), CHC11(1), CHC12(1), CHC13(1), CHC14(1), CHC15(1), CHC16(1) | [46] |
Australia | 49/471 | 10.40% | I (18), J (14), BEB4 (6), TAR_fc2 (6), TAR_fc1 (1), TAR_fc3 (1), BEB8/TAR_fc5 (1), BEB8/TAR_fc5/TAR_fc6/TAR_fc7 (1), I/TAR_fc4 (1) | [47] |
Türkiye | 29/150 | 19.33% | ERUSS1 (24), N (2), ERUSS2 (1), ERUSS3 (1), ERUSS4 (1) | [15] |
Korean | 53/314 | 16.88% | BEB8 (21), J (16), BEB4 (12), BEB8-like (2), KCALF1 (1), KCALF2 (1) | [48] |
China | 93/321 | 28.97% | J (40), I (31), BEB4 (22) | [49] |
China | 11/513 | 2.14% | I (7), CHC8 (2), EbpC (2) | [50] |
China | 30/423 | 7.09% | J (23), I (5), BEB4 (2) | [51] |
China | 31/314 | 9.87% | EbpC (14), BEB4 (12), J (2), I (1), CHG5 (1), HNC-I (1) | [10] |
Northern Spain | 2/168 | 1.2% | BEB4 (2) | [52] |
China | 5/841 | 0.59% | I (1), J (1), BEB4 (1), YNDCEB-90 (1), YNDCEB-174 (1) | [53] |
Iran | 10/32 | 31.25% | I (7), BEB6 (1), D (2) | [54] |
Bangladesh | 55/699 | 7.9% | PigEBITS7 (4), BEB4 (9), BEB6 (5), D (6), I (18), J (13) | [55] |
China | 28/108 | 25.9% | J (14), I (9), BEB4 (3), COS-I (2) | [56] |
North China | 90/401 | 22.44% | I (50), BEB4 (20), J (10), BEB6 (3), BEB8 (4), PigSpEb2 (1), CSC1 (1), CSC2 (1) | [57] |
Southeastern China | 30/556 | 5.4% | D (10), I (5), J (4), IV (4), N (1), BEB4 (1), JX-I (1), JX-II (1), JX-III (1), JX-IV (1), JX-V (1) | [58] |
China | 40/955 | 4.2% | J (26), AHDC1 (3), AHYC1 (1), AHYC2 (2), AHYC3 (2), AHYC4 (1), AHYC5 (1), AHYC6 (2), AHYC7 (1), CHN11 (1) | [59] |
Austria | 16/351 | 4.6% | J (2), I (12), BEB4 (3), BEB8 (1) | [60] |
Türkiye | 6/47 | 12.8% | Type IV, NG1, NG2, NG5, NG7 NG6 | This study |